Ignite Creation Date:
2025-12-24 @ 5:56 PM
Ignite Modification Date:
2026-01-17 @ 3:06 PM
Study NCT ID:
NCT05862168
Status:
RECRUITING
Last Update Posted:
2023-07-17
First Post:
2023-05-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Treatment of Tislelizumab Combined Chemotherapy for Locally Advanced Oral Squamous Cell Carcinoma ：A Single-arm, Prospective, Phase II Trial
Sponsor:
Organization: